Iradimed position history
The shares of Iradimed that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 24,889 shares, $1.5M, <0.01% of portfolio, New
- 2025 Q3: 28,459 shares, $2M, <0.01% of portfolio, Add +14.3%
- 2025 Q4: 26,891 shares, $2.6M, 0.01% of portfolio, Reduce −5.5%
- 2026 Q1: 20,744 shares, $2M, 0.01% of portfolio, Reduce −22.9%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|